The Outlook is Grim For Relapsing-Remitting Multiple Sclerosis (RRMS) Patients

Lemtrada strokes only add to the agony and hopelessness that RRMS patient may feel

Wednesday, May 15, 2019 - Relapsing-Remitting Multiple Sclerosis (RRMS) patients suffer ongoing periodic medical problems that gradually lead to their complete and total disability. RRMS patients experience "muscle stiffness or spasms, paralysis, typically in the legs, problems with bladder, bowel or sexual function, mental changes, such as forgetfulness or mood swings, depression, and epilepsy" according to the Mayo Clinic website. A high percentage of RRMS patient experience epileptic seizures.

Could it be possible that the terrible side effects of a drug preferable to the effects of the underlying disease? Could a paralyzing stroke leave a victim of multiple sclerosis in better condition than constantly being in a state of seizure? As tempting as it is to think that the answer to the questions above could actually be yes, Lemtrada stroke victims can continue to experience RRMS symptoms and the paralyzing stoke only adds to their agony. There is no cure for RRMS and the disease only gets worse so patients normally are willing to try just about anything to seek comfort and at least temporarily relieve their pain. Lemtrada stroke lawyers are known as national drug safety litigation leaders representing persons and loved ones of persons who have suffered a stroke while taking Lemtrada qualify for a free, no-obligation case review from our Lemtrada attorneys.

According to the National Multiple Sclerosis Society, Relapsing-Remitting Multiple Sclerosis (RRMS) patients suffer physical attacks caused by neurological problems that occur at relatively predictable intervals and also in increasing severity. The remission intervals decrease over a course of several years, and the seizures increase in frequency, severity, and duration until eventually, they become continuous. Most MS patient's symptoms increase gradually with each episode. Anti-seizure drug Lemtrada has shown to be highly effective when given to RRMS patients in increasing the remission time in between seizures and to lessen their severity. Lemtrada, however, is also known to cause paralyzing strokes. Lemtrada is to be administered by intravenous drip twice per year and only given to the most severe RRMS patients as a drug of last resort.

The Mayo Clinic describes Multiple sclerosis (MS) as "a potentially disabling disease of the brain and spinal cord (central nervous system). With MS, the immune system attacks the protective sheath (myelin) that covers nerve fibers and causes communication problems between the brain and the rest of the body. Eventually, the disease can cause permanent damage or deterioration of the nerves. The early warning signs of developing MS are "Slurred speech, fatigue, dizziness, tingling or pain in parts of your body, problems with sexual, bowel and bladder function."

Doctors and researchers are at a loss to identify what causes the body's own immune system to essentially attack itself by destroying the myelin, the fatty coating protecting the nerves in the brain and spinal cord. Women are two to three times more likely as men to develop RRMS leading researchers to suspect that environmental conditions may play a factor in the development of the disease. Those with a family history of MS also have a higher probability of contracting the condition. White European women have the highest probability of getting RRMS as well.

More Recent Lemtrada Stroke Lawsuit News:

No-Cost, No-Obligation Lemtrada Lawsuit Case Review If You or a Loved One Suffered from Lemtrada Stroke Complications

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.